Depression-what is it-and-how-to cure it

Depression: what it is, what the symptoms are, how it can be treated

Contents Index

What is depression?

Depression is a common psychiatric condition that can affect adults of all ages, from young to old, and even children.

Contrary to popular belief, depression not only affects emotions and mood, but also affects the body, altering behaviour and manifesting as physical symptoms.

This pathology can affect both men and women, but it is estimated that women are more frequently affected by depression than men.

Depression is considered a mood disorder, a crucial psychic function for adapting to our internal and external environment due to its flexibility. In case of depression, this flexibility is lost and the mood remains constantly low, regardless of the circumstances. The mood is always bad, accompanied by negative and pessimistic thoughts about yourself, others and the future.

Depression can occur at any age, regardless of race, culture, or social status. The average age of onset is around 25 years. This disorder is not related to character fragility nor does it represent a personality disorder.

It is a persistent state of mind that becomes pathological when, together with physical, physiological and cognitive changes, it significantly impairs the individual’s ability to function.

The condition occurs when a person overreacts and over a prolonged period to a triggering, emotionally distressing and stressful event, often linked to a loss.

An untreated depressive episode typically lasts about 6 months, but may persist for 2 or more years. Episodes tend to recur repeatedly throughout life, making recurrences common for those suffering from depression.

What are the symptoms of depression?

Although there are different forms of depression, which differ in duration and presumed origin, they share some emotional, physical and cognitive symptoms that significantly affect the individual’s personal, relational and social life.

People who suffer from depression see their ability to perform daily activities impaired, tend to isolate themselves and avoid social interactions, and develop feelings of guilt and feelings of self-depreciation. If these symptoms are not recognized and treated promptly, they can become chronic.

Typical symptoms of depression include:

  • Deep sadness
  • Almost total loss of interest and pleasure, which leads to abandoning passions, hobbies and pleasant activities
  • Appetite disorders (decreased or increased appetite)
  • Sleep disorders (insomnia or excessive need to sleep)
  • Chronic fatigue
  • Memory problems
  • Difficulty concentrating
  • Lack of planning and difficulty in making daily decisions
  • Negative thoughts, including suicide

The presence of at least five of these symptoms may indicate a depressive condition, which must include at least one depressive episode lasting at least two weeks. Often, psychomotor slowdown and somatic symptoms are also added to these symptoms.

Types of depression

The term “depression” does not refer to a single disease, but includes several forms of depression, each with specific characteristics. Here are some of the main types:

  1. Unipolar depression or major depressive disorder: This is one of the most severe forms of depression, whose symptoms prevent you from performing normal daily activities, such as sleeping and eating, as well as negatively affecting activities that normally bring pleasure.
  2. Dysthymic disorder or dysthymia: Characterized by symptoms similar to those of major depression, but in a milder and more persistent form.
  3. Depressive disorder not otherwise specified: This category includes depressive disorders that do not fall into other specific diagnostic categories.
  4. Bipolar disorders or manic-depressive disorders: These disorders are characterized by the alternation between depressive states and manic or hypomanic states. Bipolar disorders are divided into:
    • Bipolar I disorder: Characterized by at least one episode of mania or mixed alternating with depressive episodes.
    • Bipolar Disorder Type II: Characterized by episodes of hypomania (never mania) alternating with depressive episodes.
    • Cyclothymic disorder or cyclothymia: It has a minimum duration of two years and is manifested by alternating mild to moderate depressive episodes and hypomanic episodes.

These forms of depression, with their respective characteristics, are described in detail in the Diagnostic and Statistical Manual of Mental Disorders (DSM), currently in its fifth edition.

There are also other types of depression classified by etiology:

  • Premenstrual dysphoric disorder: It includes a series of affective, behavioral and somatic symptoms that occur monthly during the luteal phase of the menstrual cycle.
  • Depressive disorder due to another physical condition.
  • Drug or substance-induced depressive disorder (iatrogenic depressive disorder).

Causes of depression

The etiology of depression is not entirely clear. However, its appearance can be influenced by a combination of predisposing or precipitating factors of a biological, psychological, social, genetic and physiological nature. Among these, heredity, side effects of certain medicines, hormonal and organic imbalances, traumatic events such as bereavement, severe interpersonal and family conflicts, life changes and physical illnesses may play a significant role.

About half of people with depression have a familial predisposition linked to genetic factors that alter the normal functioning of certain neurotransmitters (serotonin, dopamine, norepinephrine), negatively affecting initiative, sleep, obsessive thoughts and social interactions.

Changes in female hormone levels can cause significant mood changes, which are particularly noticeable shortly before menstruation, during pregnancy and especially in the postpartum period (postpartum depression).

Depression can also be caused by thyroid dysfunction due to pathologies of the gland or as an indirect consequence of a painful or disabling disease that compromises the quality of life of the affected person.

Seasonal affective disorder is an example of how climate and environmental changes can induce severe forms of depression in particularly sensitive individuals. Some medications, such as beta-blockers and corticosteroids, may also contribute to depressive states, especially when they are stopped.

Some mental illnesses, such as anxiety disorders, alcohol and other substance use disorder, and schizophrenia, may predispose you to depression. In addition, events that generate emotional distress can promote depression in predisposed individuals.

Role of neurotransmitters in depression

Regarding the role of neurotransmitters in depression, some hypotheses have been formulated including:

  1. Monoaminergic hypothesis: This theory holds that depression is caused by a deficiency of serotonin, norepinephrine and dopamine. The theory is supported by the fact that antidepressant drugs increase the transmission of these monoamines.
  2. Hypothesis of receptor sensitivity: According to this hypothesis, depression is not only due to a monoamine deficiency, but also to an altered sensitivity of postsynaptic receptors to these neurotransmitters.
  3. Permissive hypothesis: This theory underlines the importance of the reciprocal balance between serotonin and norepinephrine in mood regulatory processes. Too low a level of serotonin can disrupt the regulation of norepinephrine, leading to mania. In contrast, a drop in norepinephrine can disrupt serotonin regulation, causing symptoms of depression.
  4. Hormonal hypothesis: This hypothesis suggests that alteration of the hypothalamic-pituitary-adrenal (HPA) axis may affect the levels of serotonin and norepinephrine released by neurons and impair their functioning.

Traditional therapies to treat depression

When the origin of depression indicates a psychosocial nature, a path often traveled and cognitive-behavioral therapy, which focuses on the present and current symptoms.

This therapy attempts to modify the negative thoughts that contribute to depression, helping the person develop more balanced and rational thinking. In addition, it works to improve the person's coping skills, encouraging them to gradually resume abandoned activities, starting with the most pleasant ones, and to develop more functional behaviors.

Drug therapy with antidepressants, which is predominantly symptomatic, becomes necessary when depressive symptoms are so severe as to compromise social, professional and relational life. Although these drugs are widely used, the results can be modest and temporary.

Several classes of drugs are used in the treatment of depression: tricyclic and tetracyclic antidepressants, multisystem agonists Noradrenaline-Serotonin, and serotonin reuptake inhibitors (SSRIs).

For resistant depression, combinations with mood stabilizers may be used. If depression is accompanied by psychotic symptoms, the use of a combination of antidepressants and antipsychotics is justified. In any case, it is essential to integrate drug therapy with a valid psychotherapy, to help the person develop functional strategies to deal with acute depressive episodes and prevent relapses.

However, all these therapies tend to treat the symptoms without being able to dig into the neuro-psycho-physiopathological depth from which all dysfunctional processes start.

Innovative therapies: Neurobiological Modulation with REAC Technology?

The REAC technology? (Radio Electric Asymmetric Conveyer), implemented in medical devices B.E.N.E. (Neuro Enhancer Bio Enhancer), produced and distributed by the holding ASMED® by Scandicci (FI), is an innovative technique of Neuro-biological modulation developed and patented by doctors and researchers Salvatore Rinaldi and Vania Fontani, Founders of the?Rinaldi Fontani Institute of Florence. This treatment is proposed as a non-invasive and side-effect-free solution for various dysfunctional conditions with a strong neuro-psycho-physiological component, including depression.

Through specific therapeutic protocols, REAC Technology Helps Restore Natural Neurotransmission Responses, reducing the effects of anxiety and stress that They are often at the root of the problem. It complicates healing and recovery.

The REAC Neuro-Biological Modulation? uses very low-intensity electric radio waves to modulate the activity of the nervous system and other biological systems. Numerous studies published in prestigious scientific journals attest to its effectiveness and safety. Some of these publications are freely available on the scientific medical portal PubMed.

 

RELATED ARTICLES

SIGN UP FOR THE NEWSLETTER

Subscribe to the newsletter to stay informed about new publications and initiatives of the Rinaldi Fontani Institute.

Dr. Vania Fontani

Doctor Surgeon
Neurophysiopathologist
Physical Medicine and Rehabilitation
Master II Liv. in Neuro Psycho Pathophysiology and Optimization Neuro Physical Psycho

Register of Professional Association of Physicians of Florence and Province No. 9096

Co-founder and Health Director of the Rinaldi Fontani Institute

Co-founder and Scientific Director of IRF Shanghai Medical Science Co., Ltd – Shanghai, China

President of the Italian Society of Neuro-Psycho-Physical Optimization (SONC)

Vice President of the International Society of Neuroscience for Neuro Psycho Physical Optimization (ISNPO)

 

Professional path:

Since 1989 he has been a lecturer in second-level university master’s degrees and university master’s courses on adaptive neurophysiopathology and neuro-psycho-physical optimisation at the faculties of Medicine and Surgery G. D’Annunzio – Chieti, Tor Vergata – Rome and Florence.
Speaker at national and international congresses.
In his research activity he defined four international patents concerning the technology of conveyed radio fields and the modulation of cellular reprogramming through these. It also defined a national patent for a measuring instrument for anatomical-functional misalignments.

 

Publications in international peer reviewed scientific journals indexed on PubMed:

Long-Lasting Efficacy of Radio Electric Asymmetric Conveyer Neuromodulation Treatment on Functional Dysmetria, an Adaptive Motor Behavior. Fontani V, Rinaldi A, Rinaldi C, et al. Cureus. 2022 Jun 8; 14(6): e25768. doi:10.7759/cureus.25768

Radio Electric Asymmetric Conveyer Tissue Reparative Treatment on Post-surgical Breast Skin Necrosis. A Report of Four Cases. Fontani V, Coelho Pereira JA, Rinaldi S. Cureus. 2022 Jun 5;14(6):e25666. doi: 10.7759/cureus.25666. eCollection 2022 Jun.

Radio Electric Asymmetric Conveyer Reparative Effects on Muscle Injuries: A Report of Two Cases. Chestnut A, Fontani V, Rinaldi S. Cureus. 2022 May 11;14(5):e24904. doi: 10.7759/cureus.24904. eCollection 2022 May.



REAC-induced endogenous bioelectric currents in the treatment of venous ulcers: a three-arm randomized controlled prospective study. Elio C, Fontani V, Rinaldi S, Gasbarro V. Acta Dermatovenerol Alp Pannonica Adriat. 2020 Sep;29(3):109-113. PMID: 32975296.

REAC neurobiological treatments in acute post-traumatic knee medial collateral ligament lesion. Barcessat ARP, Bittencourt MN, Pereira JAC, Castagna A, Fontani V, Rinaldi S. Heliyon. 2020 Jul 24;6(7):e04539. doi: 10.1016/j.heliyon.2020.e04539. PMID: 32743108; PMCID: PMC7385461.

Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress. Rinaldi A, Rinaldi C, Coelho Pereira JA, Lotti Margotti M, Bittencourt MN, Barcessat ARP, Fontani V, Rinaldi S. Neuropsychiatric Disease and Treatment 2019:15 469?480.

Physical stimulation by REAC and BMP4/WNT-1 inhibitor synergistically enhance cardiogenic commitment in iPSCs. Basoli V, Santaniello S, Rinaldi S, Fontani V, Pigliaru G, Wieser M, Strajeriu A, Castagna A, Redl H, Ventura C, Grillari R, Maioli M.
PLoS One. 2019 Jan 23;14(1):e0211188. doi: 10.1371/journal.pone.0211188. eCollection 2019.

Radio Electric Asymmetric Conveyer (REAC) technology to obviate loss of T cell responsiveness under simulated microgravity. Rinaldi S, Meloni MA, Galleri G, Maioli M, Pigliaru G, Cugia G, Santaniello S, Castagna A, Fontani V. PLoS One. 2018 Jul 6;13(7):e0200128. doi: 10.1371/journal.pone.0200128. eCollection 2018.

REAC neuromodulation treatments in subjects with severe socio-economic and cultural hardship in the Brazilian state of Pará: A family observational pilot study. Coelho Pereira JA, Rinaldi A, Fontani V, Rinaldi S. Neuropsychiatr Dis Treat. 2018 Apr 16;14:1047-1054.
doi: 10.2147/NDT.S161646. eCollection 2018.

Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a Mouse Model of Neurodegeneration.
Panaro MA, Aloisi A, Nicolardi G, Lofrumento DD, De Nuccio F, La Pesa V, Cianciulli A, Rinaldi R, Calvello R, Fontani V, Rinaldi S. Neurosci Bull. 2017 Nov 10. doi: 10.1007/s12264-017-0188-0.

REAC technology as optimizer of stallion spermatozoa liquid storage. Berlinguer F, Pasciu V, Succu S, Cossu I, Caggiu S, Addis D, Castagna A, Fontani V, Rinaldi S, Passino ES. Reprod Biol Endocrinol. 2017 Feb 8;15(1):11. doi: 10.1186/s12958-017-0229-6.

REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer’s disease mouse model. Lorenzini L, Giuliani A, Sivilia S, Baldassarro VA, Fernandez M, Margotti ML, Giardino L, Fontani V, Rinaldi S, Calzà L. Sci Rep. 2016 Nov 18;6:37483. doi: 10.1038/srep37483.

REAC technology and hyaluron synthase 2, an interesting network to slow down stem cell senescence. Maioli M, Rinaldi S, Pigliaru G, Santaniello S, Basoli V, Castagna A, Fontani V, Ventura C. Sci Rep. 2016 Jun 24;6:28682.

Osteogenesis from Dental Pulp Derived Stem Cells: A Novel Conditioned Medium Including Melatonin within a Mixture of Hyaluronic, Butyric, and Retinoic Acids.Maioli M, Basoli V, Santaniello S, Cruciani S, Delitala AP, Pinna R, Milia E, Grillari-Voglauer R, Fontani V, Rinaldi S, Muggironi R, Pigliaru G, Ventura C. Stem Cells Int. 2016;2016:2056416. doi: 10.1155/2016/2056416. Epub 2016 Jan 10.

Electrophysiological effects of non-invasive Radio Electric Asymmetric Conveyor (REAC) on thalamocortical neural activities and perturbed experimental conditions. Zippo AG, Rinaldi S, Pellegata G, Caramenti GC, Valente M, Fontani V, Biella GE. Ski Rep. 2015 Dec 11;5:18200.

Neurological morphofunctional differentiation induced by REAC technology in PC12. A neuro protective model for Parkinson’s disease. Maioli M, Rinaldi S, Migheli R, Pigliaru G, Rocchitta G, Santaniello S, Basoli V, Castagna A, Fontani V, Ventura C, Serra PA. Ski Rep. 2015 May 15;5:10439. doi: 10.1038/srep10439.

Radio electric asymmetric conveyer: a novel neuromodulation technology in Alzheimer’s and other neurodegenerative diseases. Rinaldi S, Calzà L, Giardino L, Biella GE, Zippo AG, Fontani V. Front Psychiatry. 2015 Feb 17;6:22.

Stem cell senescence. Effects of REAC technology on telomerase-independent and telomerase-dependent pathways. Rinaldi S, Maioli M, Pigliaru G, Castagna A, Santaniello S, Basoli V, Fontani V, Ventura C. Sci Rep. 2014 Sep 16;4:6373.

Long-lasting changes in brain activation induced by a single REAC technology pulse in Wi-Fi bands. Randomized double-blind fMRI qualitative study. Rinaldi S, Mura M, Castagna A, Fontani V. Sci Rep. 2014 Jul 11;4:5668. doi: 10.1038/srep05668.

Motor Effects of Radio Electric Asymmetric Conveyer in Alzheimer’s Disease: Results from a Cross-Over Trial. Olazarán J, González B, Osa-Ruiz E, Felipe-Ruiz S, Boyano I, Fontani V, Castagna A, Mendoza C, Zea MA, Frades B, Rinaldi S, Martínez-Martín P. J Alzheimers Dis. 2014 May 30.

Radio electric asymmetric conveyed fields and human adipose-derived stem cells grown with a non-enzymatic method and device: A novel approach to multipotency. Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Delitala A, Bianchi F, Tremolada C, Fontani V, Ventura C. Cell Transplant. 2013 Aug 30.

Effects of regenerative radioelectric asymmetric conveyer treatment on human normal and osteoarthritic chondrocytes exposed to IL-1?. A biochemical and morphological study.
Collodel G, Fioravanti A, Pascarelli NA, Lamboglia A, Fontani V, Maioli M, Santaniello S, Pigliaru G, Castagna A, Moretti E, Iacoponi F, Rinaldi S, Ventura C.Clin Interv Aging. 2013;8:309-16. doi: 10.2147/CIA.S42229. Epub 2013 Mar 19.

Anti-senescence efficacy of radio-electric asymmetric conveyer technology. Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Delitala A, Lotti Margotti M, Bagella L, Fontani V, Ventura C. Age (Dordr). 2013 May 9.

Physical reparative treatment in reptiles.
Rinaldi S, Iannaccone M, Magi GE, Costantini E, Castagna A, Sanna Passino E, Maioli M, Fontani V.
BMC Vet Res. 2013 Feb 26;9(1):39.

The effect of radio electric asymmetric conveyer treatment on sperm parameters of subfertile stallions: A pilot study. Collodel G, Rinaldi S, Moretti E, Fontani V, Castagna A, Iacoponi F, Terzuoli G, Cubeddu F, Careddu GM, Cossu I, Passino ES. Reprod Biol. 2012 Nov;12(3):277-84. Epub 2012 Oct 22.

Radio Electric Conveyed Fields Directly Reprogram Human Dermal-Skin Fibroblasts Towards Cardiac-, Neuronal-, and Skeletal Muscle-Like Lineages. Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Gualini S, Cavallini C, Fontani V, Ventura C. Cell Transplant. 2012 Oct 2.

Regenerative treatment using a radioelectric asymmetric conveyor as a novel tool in antiaging medicine: an in vitro beta-galactosidase study. Rinaldi S, Maioli M, Santaniello S, Castagna A, Pigliaru G, Gualini S, Margotti ML, Carta A, Fontani V, Ventura C. Clin Interv Aging. 2012;7:191-4. Epub 2012 Jun 29.

Preliminary pilot fMRI study of neuropostural optimization with a noninvasive asymmetric radioelectric brain stimulation protocol in functional dysmetry. Mura M, Chestnut A, Fontani V, Rinaldi S. Neuropsychiatr Dis Treat. 2012;8:149-54. Epub 2012 Apr 4.

Neuropsychophysical optimization by REAC technology in the treatment of: Sense of stress and confusion. Psychometric evaluation in a randomized, single blind, sham-controlled naturalistic study. Fontani V, Aravagli L, Margotti ML, Castagna A, Mannu P, Rinaldi S. Patient Prefer Adherence. 2012;6:195-9. Epub 2012 Mar 19.

Noninvasive radioelectric asymmetric conveyor brain stimulation treatment improves balance in individuals over 65 suffering from neurological diseases: Pilot study. Fontani V, Rinaldi S, Castagna A, Margotti ML. Ther Clin Risk Manag. 2012;8:73-8. Epub 2012 Feb 17.

Social Anxiety Disorder: radio electric asymmetric conveyor brain stimulation versus sertraline. Fontani V, Mannu P, Castagna A, Rinaldi S. Patient Prefer Adherence. 2011;5:581-6. Epub 2011 Nov 22.

Noninvasive brain stimulation by radioelectric asymmetric conveyor in the treatment of agoraphobia: open-label, naturalistic study. Mannu P, Rinaldi S, Fontani V, Castagna A, Margotti ML. Patient Prefer Adherence. 2011;5:575-80. Epub 2011 Nov 18.

Brain activity modification produced by a single radioelectric asymmetric brain stimulation pulse: a new tool for neuropsychiatric treatments. Preliminary fMRI study. Rinaldi S, Fontani V, Chestnut A. Neuropsychiatr Dis Treat. 2011;7:649-54. Epub 2011 Oct 28.

Noninvasive radioelectric asymmetric brain stimulation in the treatment of stress-related pain and physical problems: Psychometric evaluation in a randomized, single-blind placebo-controlled, naturalistic study. Fontani V, Rinaldi S, Aravagli L, Mannu P, Castagna A, Margotti ML. Int J Gen Med. 2011;4:681-6. Epub 2011 Sep 22.

Radio Frequency Energy Loop Primes Cardiac, Neuronal, and Skeletal Muscle Differentiation in Mouse Embryonic Stem Cells: A New Tool for Improving Tissue Regeneration.
Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Gualini S, Fontani V, Ventura C. Cell Transplant. 2011 Sep 22.

Radioelectric asymmetric stimulation of tissues as treatment for post-traumatic injury symptoms. Fontani V, Castagna A, Mannu P, Rinaldi S. Int J Gen Med. 2011;4:627-34. Epub 2011 Aug 26.

Radio electric tissue optimization in the treatment of surgical wounds. Chestnut A, Fontani V, Rinaldi S, Mannu P. Clin Cosmet Investig Dermatol. 2011;4:133-7. Epub 2011 Aug 25.

Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: A pilot study. Olivieri EB, Vecchiato C, Ignaccolo N, Mannu P, Castagna A, Aravagli L, Fontani V, Rinaldi S. Neuropsychiatr Dis Treat. 2011;7:449-55. Epub 2011 Aug 4.

Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor. Mannu P, Rinaldi S, Fontani V, Chestnut A .Neuropsychiatr Dis Treat. 2011;7:373-9. Epub 2011 Jun 15.

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer's disease. Mannu P, Rinaldi S, Fontani V, Castagna A.
Clin Interv Aging. 2011;6:207-11. Epub 2011 Jul 26.

Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation. Chestnut A, Rinaldi S, Fontani V, Mannu P, Margotti ML.
Clin Interv Aging. 2011;6:201-6. Epub 2011 Jul 25.

Radioelectric asymmetric brain stimulation and lingual apex repositioning in patients with atypical deglutition. Chestnut A, Rinaldi S, Fontani V, Mannu P. J Multidiscip Healthc. 2011;4:209-13. Epub 2011 Jun 21.

Stress-related psycho-physiological disorders: randomized single blind placebo controlled naturalistic study of psychometric evaluation using a radio electric asymmetric treatment.
Rinaldi S, Fontani V, Aravagli L, Mannu P, Castagna A, Margotti ML, Rosettani B. Health Qual Life Outcomes. 2011 Jul 19;9:54.

Psychological and symptomatic stress-related disorders with radio-electric treatment: Psychometric evaluation. Rinaldi S, Fontani, V., Aravagli, L., Lotti Margotti, M. Stress and Health. 2010;26(5):350-358.

A new approach on stress-related depression & anxiety: Neuro-Psycho-Physical-Optimization with Radio Electric Asymmetric-Conveyer. Rinaldi S, Fontani V, Moretti E, Rosettani B, Aravagli L, Saragò G, Collodel G. Indian J Med Res. 2010 Aug;132:189-94.

Does osteoarthritis of the knee also have a psychogenic component? Psycho-emotional treatment with a radio-electric device vs. intra-articular injection of sodium hyaluronate: an open-label, naturalistic study. Chestnut A, Rinaldi S, Fontani V, Aravagli L, Mannu P, Margotti ML. Acupunct Electrother Res. 2010;35(1-2):1-16.

Psychometric evaluation of a radio electric auricular treatment for stress related disorders: a double-blinded, placebo-controlled pilot study. Rinaldi S, Fontani V, Aravagli L, Mannu P. Health Qual Life Outcomes. 2010 Mar 20;8:31.

Radio electric treatment vs. Es-Citalopram in the treatment of panic disorders associated with major depression: an open-label, naturalistic study. Mannu P, Rinaldi S, Fontani V, Castagna A, Margotti ML. Acupunct Electrother Res. 2009;34(3-4):135-49.

Effect of emotional stress on sperm quality. Collodel G, Moretti E, Fontani V, Rinaldi S, Aravagli L, Saragò G, Capitani S, Anichini C. Indian J Med Res. 2008 Sep;128(3):254-61.

5 x 1000

Donate now! Your contribution makes a difference!
Help us to overcome suffering and disease with the medical and scientific research of the Rinaldi Fontani Foundation

Your donation is a very important support and costs you nothing! To do so, simply indicate in the tax return (single, model 730, CUD) in the dedicated section, your support for:

Rinaldi Fontani Foundation
C.F. : 94237060481

 

Rinaldi Fontani FoundationThank you for your support!